Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Small hepatocellular carcinoma: Is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?
Radiology, 07/02/09
Shibata T et al. - In a study to prospectively compare combined radiofrequency ablation and transcatheter arterial chemoembolization (TACE) with radiofrequency ablation alone for treatment of small (3 cm) hepatocellular carcinomas (HCCs), it appears that combined radiofrequency ablation plus TACE and radiofrequency ablation alone have equivalent effectiveness for treatment of small HCCs, so the combination treatment may not be necessary.
Methods- 89 pts with 93 HCC nodules 0.8–3.0 cm in diameter were randomly treated with combined radiofrequency ablation and TACE (46 pts with 49 nodules) or with radiofrequency ablation alone (43 pts with 44 nodules).
- Patients were followed up for 9–68 mos.
- Rates of local tumor progression (LTP), overall survival (OS), local progression-free survival (PFS), and event-free survival (EFS) were evaluated by using the Kaplan-Meier method.
- 1-, 2-, 3-, and 4-yr rates of LTP, OS, local PFS, and recurrence-free survival were as follows: LTP rates were 14.4%, 17.6%, 17.6%, and 17.6%, respectively, in combined treatment group and 11.4%, 14.4%, 14.4%, and 14.4%, respectively, in radiofrequency ablation group.
- OS rates were 100%, 100%, 84.8%, and 72.7%, respectively, in combined treatment group and 100%, 88.8%, 84.5%, and 74.0%, respectively, in radiofrequency ablation group.
- Local PFS rates were 84.6%, 81.1%, 69.7%, and 55.8%, respectively, in combined treatment group and 88.4%, 74.1%, 74.1%, and 61.7%, respectively, in radiofrequency ablation group.
- EFS rates were 71.3%, 59.9%, 48.8%, and 36.6%, respectively, in combined treatment group and 74.3%, 52.4%, 29.7%, and 29.7%, respectively, in radiofrequency ablation group.
Today in Gastrointestinal...keeping you current
Receive free subspecialty "5-minute updates" via email
CT Colonography: Coming of Age
American Journal of Roentgenology, 10/30/09
Esophageal perforation during esophagogastroduodenoscopy
The American Journal of Surgery, 11/03/09
Endoscopic ultrasonography-guided biliary drainage
Journal of Hepato-Biliary-Pancreatic Surgery, 10/09/09
Today in Radiotherapy (XRT)...keeping you current
Receive free subspecialty "5-minute updates" via email
Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer
Cochrane Reviews, 10/09/09
Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer
Cochrane Reviews, 10/09/09
Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2×2 randomised clinical trial in patients with low risk of recurrence
European Journal of Cancer, 11/05/09
Sponsor
Article Search
Sponsor


See Latest Articles


